All In Biotech

Free tool

FAERS Monitor: Tetracaine Hydrochloride

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 210821 or its brand name (Tetracaine Hydrochloride, Tetracaine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

133

Serious

118

89% of reports

Hospitalization

29

Death reported

17

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • toxic anterior segment syndrome31
  • nausea15
  • syncope15
  • aqueous fibrin14
  • inflammation14
  • abdominal discomfort12
  • pain12
  • sudden death12
  • muscle spasms11
  • oropharyngeal pain11
  • hypersensitivity9
  • hypotension9
  • bradycardia8
  • cardio-respiratory arrest8
  • circulatory collapse8

Reports by year received

View as table
YearReports
20041
20061
20082
20094
20103
20111
201211
20131
20141
20151
20162
20173
201815
20196
20204
20218
202227
20236
20247
202512
202617

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,026 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
aqueous fibrinSignal1459897.733168.0565,675
toxic anterior segment syndromeSignal314629.63381.6134,924
sudden deathSignal12179.5104.61,955
circulatory collapseSignal874.337.9508
inflammationSignal1442.926.1533
cardio-respiratory arrestSignal830.315.5198
bradycardiaSignal823.912.2153
syncopeSignal1523.714.7305
oropharyngeal painSignal1118.810.7169
abdominal discomfortSignal1211.36.6104
muscle spasmsSignal119.55.476
hypersensitivitySignal97.74.146
hypotensionSignal97.13.842
painSignal123.11.815
nauseaSignal153.01.919

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.